Please use this identifier to cite or link to this item: http://hdl.handle.net/20.500.12857/115847
Title: Treatment and prognostic factors in pleuropulmonary blastoma: an EXPeRT report
Authors: Bisogno, Gianni 
Brennan, Bernadette
Orbach, Daniel
Stachowicz-Stencel, Teresa
Cecchetto, Giovanni 
Indolfi, Paolo
Bien, Ewa
Ferrari, Andrea
Dommange-Romero, Florence
Keywords: Chemotherapy;Children;EXPeRT;Pleuropulmonary blastoma;TREP project;Very rare tumours
Keywords Plus: DICER1 MUTATIONS;RARE TUMORS;CHILDREN;CHILDHOOD;REGISTRY;ADOLESCENTS;EXPERIENCE
Mesh headings: Pulmonary Blastoma
Secondary Mesh headings: Adolescent;Antineoplastic Combined Chemotherapy Protocols;Child;Child, Preschool;Disease-Free Survival;Europe;Female;Humans;Infant;Infant, Newborn;Male;Prognosis;Rare Diseases;Survival Analysis
Issue Date: Jan-2014
Publisher: ELSEVIER SCI LTD
Journal: European journal of cancer (Oxford, England : 1990) 
Abstract: 
Pleuropulmonary blastoma (PPB) is an aggressive embryonal malignancy presenting in early childhood, presumably arising from pleuropulmonary mesenchyme. The European Cooperative Study Group for Paediatric Rare Tumours (EXPeRT) analysed its data on this tumour.
URI: http://hdl.handle.net/20.500.12857/115847
ISSN: 09598049
DOI: 10.1016/j.ejca.2013.08.015
Appears in Collections:Articles

Show full item record

PubMed Central
Citations 50

10
Last Week
0
Last month
0
checked on Nov 28, 2021

SCOPUSTM   
Citations

31
checked on Aug 31, 2020

WEB OF SCIENCETM
Citations

42
checked on Nov 24, 2021

Page view(s) 5

2
checked on Nov 29, 2021

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.